Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CadAI-B Dx

K-Number: K260086 · 2026-08-12

Decision Date2026-08-12
Product CodeQDQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CadAI-B Dx is the device name listed in this FDA 510(k) record. The listed applicant is BeamWorks, Inc.. It received FDA 510(k) clearance on 2026-08-12 under 510(k) number K260086. The device is classified under product code QDQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CadAI-B Dx?

CadAI-B Dx is a medical device that received FDA 510(k) clearance on 2026-08-12. The listed applicant is BeamWorks, Inc.. The 510(k) number is K260086.

When did CadAI-B Dx receive FDA 510(k) clearance?

CadAI-B Dx received FDA 510(k) clearance on 2026-08-12, under 510(k) number K260086.

Who is the listed applicant for CadAI-B Dx?

The FDA 510(k) record lists BeamWorks, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CadAI-B Dx?

The FDA product code for CadAI-B Dx is QDQ.

Related Devices (Code: QDQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.